Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Lennart Tonneijck; Mark M. Smits; Marcel H. A. Muskiet; Trynke Hoekstra; Mark H. H. Kramer; A. H. Jan Danser; Michaela Diamant; Jaap A. Joles; Daniel H. van Raalte

doi:10.1007/s00125-016-3938-z

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Lennart Tonneijck, Mark M. Smits, Marcel H. A. Muskiet, Trynke Hoekstra, Mark H. H. Kramer, A. H. Jan Danser, Michaela Diamant, Jaap A. Joles, Daniel H. van Raalte

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1412-1421
Journal	Diabetologia
Volume	59
Issue number	7
DOIs	https://doi.org/10.1007/s00125-016-3938-z
Publication status	Published - Jul 2016

Access to Document

10.1007/s00125-016-3938-z

Cite this

Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., ... van Raalte, D. H. (2016). Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. Diabetologia, 59(7), 1412-1421. https://doi.org/10.1007/s00125-016-3938-z

Tonneijck, Lennart ; Smits, Mark M. ; Muskiet, Marcel H. A. ; Hoekstra, Trynke ; Kramer, Mark H. H. ; Danser, A. H. Jan ; Diamant, Michaela ; Joles, Jaap A. ; van Raalte, Daniel H. / Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. In: Diabetologia. 2016 ; Vol. 59, No. 7. pp. 1412-1421.

@article{e42174a21f504dc79eb0511dbe3b52ec,

title = "Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial",

keywords = "Diabetes, Exenatide, Glomerular filtration rate, Glomerular hyperfiltration, GLP-1 receptor agonist, Glucagon-like peptide-1, Renal function, Renal haemodynamics, Type 2 diabetes",

author = "Lennart Tonneijck and Smits, {Mark M.} and Muskiet, {Marcel H. A.} and Trynke Hoekstra and Kramer, {Mark H. H.} and Danser, {A. H. Jan} and Michaela Diamant and Joles, {Jaap A.} and {van Raalte}, {Daniel H.}",

year = "2016",

month = "7",

doi = "10.1007/s00125-016-3938-z",

language = "English",

volume = "59",

pages = "1412--1421",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

number = "7",

}

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial. / Tonneijck, Lennart ; Smits, Mark M.; Muskiet, Marcel H. A.; Hoekstra, Trynke ; Kramer, Mark H. H.; Danser, A. H. Jan; Diamant, Michaela; Joles, Jaap A.; van Raalte, Daniel H.

In: Diabetologia, Vol. 59, No. 7, 07.2016, p. 1412-1421.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

AU - Tonneijck, Lennart

AU - Smits, Mark M.

AU - Muskiet, Marcel H. A.

AU - Hoekstra, Trynke

AU - Kramer, Mark H. H.

AU - Danser, A. H. Jan

AU - Diamant, Michaela

AU - Joles, Jaap A.

AU - van Raalte, Daniel H.

PY - 2016/7

Y1 - 2016/7

KW - Diabetes

KW - Exenatide

KW - Glomerular filtration rate

KW - Glomerular hyperfiltration

KW - GLP-1 receptor agonist

KW - Glucagon-like peptide-1

KW - Renal function

KW - Renal haemodynamics

KW - Type 2 diabetes

U2 - 10.1007/s00125-016-3938-z

DO - 10.1007/s00125-016-3938-z

M3 - Article

C2 - 27038451

VL - 59

SP - 1412

EP - 1421

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 7

ER -